Skip to main content
Log in

Cardiomyoblast apoptosis induced by insulin-like growth factor (IGF)-I resistance is IGF-II dependent and synergistically enhanced by angiotensin II

  • Reports
  • Published:
Apoptosis Aims and scope Submit manuscript

Abstract

Objective: This study explores the synergistic effect of cardiomyoblast apoptosis induced by angiotensin II (Ang II) and Insulin-like growth factor (IGF)-I resistance, and elucidates the role of IGF-II via IGF-II receptor (R) and calcineurin pathways in apoptosis induced by Ang II and IGF-I resistance. Methods: Apoptosis of cultured cardiomyoblast H9c2 cells was assessed by DNA fragmentation on agarose gel electrophoresis, nuclear condensation stained with DAPI, and Western blot analysis of pro-apoptotic Bad and cytochrome c in various combinations of control, Ang II, antisense IGF (I or II), IGF (I or II) antibody, IGF (I or II) receptor (R) antibody, or calcineurin inhibitor (Cyclosporine A, (CsA)). Results: We found the following: (1) The combination of Ang II and IGF-I deficiencies had a synergistic effect on apoptosis, confirmed by DNA fragmentation, nuclei condensation, and increases in such pro-apoptotic proteins as Bad, cytochrome c, caspase 9, and caspase 3 in H9c2 cells. (2) IGF-II and IGF-IIR protein products were increased by antisense IGF-I and IGF-I resistance, but these IGF-II protein products were not affected by sense IGF-I and non-specific antibody IgG in H9c2 cells. (3) The alteration of Bad protein level and the release of cytochrome c, both induced by treatments containing combinations of Ang II and antisense IGF-I, IGF-I antibody or IGF-IR antibody, were inhibited by IGF-II antibody. (4) DNA fragmentation, Bad, and cytochrome c which was induced by treatments combining IGF-IR antibody with Ang II or combining IGF-IR antibody with IGF-II were remarkably attenuated by CsA. Conclusion: IGF-I deficiency and/or IGF-IR resistance induced apoptosis in cardiomyoblast cells. The apoptosis, which might have been caused by the upregulation of IGF-II and IGF-IIR genes possibly activated the downstream calcineurin pathway, was synergistically augmented by Ang II.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Filippatos G, Tilak M, Pinillos H, Uhal BD (2001) Regulation of apoptosis by angiotensin II in the heart and lungs. Int J Mol Med 7:273–280

    PubMed  CAS  Google Scholar 

  2. Adams V, Gielen S, Hambrecht R, Schuler G (2001) Apoptosis in skeletal muscle. Front Biosci 6:D1–D11

    PubMed  CAS  Google Scholar 

  3. Harrison DG, Cai H, Landmesser U, Griendling KK (2003) Interactions of angiotensin II with NAD(P)H oxidase, oxidant stress and cardiovascular disease. J Renin Angiotensin Aldosterone Syst 4:51–61

    PubMed  CAS  Google Scholar 

  4. Kang YJ (2001) Molecular and cellular mechanisms of cardiotoxicity. Environ Health Perspect 109(Suppl 1):27–34

    PubMed  CAS  Google Scholar 

  5. Thrailkill KM (2000) Insulin-like growth factor-I in diabetes mellitus: its physiology, metabolic effects, and potential clinical utility. Diabetes Technol Ther 2:69–80

    Article  PubMed  CAS  Google Scholar 

  6. Tappy L, Fujita-Yamaguchi Y, LeBon TR, Boden G (1988) Antibodies to insulin-like growth factor I receptors in diabetes and other disorders. Diabetes 37:1708–1714

    PubMed  CAS  Google Scholar 

  7. Ren J, Samson WK, Sowers JR (1999) Insulin-like growth factor I as a cardiac hormone: Physiological and pathophysiological implications in heart disease. J Mol Cell Cardiol 31:2049–2061

    Article  PubMed  CAS  Google Scholar 

  8. Fujio Y, Nguyen T, Wencker D, Kitsis RN, Walsh K (2000) Akt promotes survival of cardiomyocytes in vitro and protects against ischemia-reperfusion injury in mouse heart. Circulation 101:660–667

    PubMed  CAS  Google Scholar 

  9. Parrizas M, Saltiel AR, LeRoith D (1997) Insulin-like growth factor I inhibits apoptosis using the phosphatidylinositol 3′-kinase and mitogen-activated protein kinase pathways. J Biol Chem 272:154–161

    Article  PubMed  CAS  Google Scholar 

  10. Chao W, Matsui T, Novikov MS, et al (2003) Strategic advantages of insulin-like growth factor-I expression for cardioprotection. J Gene Med 52:277–286

    Google Scholar 

  11. O’Connor R, Kauffmann-Zeh A, Liu Y, et al (1997) Identification of domains of the insulin-like growth factor I receptor that are required for protection from apoptosis. Mol Cell Biol 17:427–435

    PubMed  CAS  Google Scholar 

  12. LeRoith D, Werner H, Beitner-Johnson D, Roberts CT Jr (1995) Molecular and cellular aspects of the insulin-like growth factor I receptor. Endocr Rev 16:143–163

    Article  PubMed  CAS  Google Scholar 

  13. Huang CY, Hao LY, Buetow DE (2002) Hypertrophy of cultured adult rat ventricular cardiomyocytes induced by antibodies against the insulin-like growth factor (IGF)-I or the IGF-I receptor is IGF-II-dependent. Mol Cell Biochem 233:65–72

    Article  PubMed  CAS  Google Scholar 

  14. Adachi S, Ito H, Akimoto H, et al (1994) Insulin-like growth factor-II induces hypertrophy with increased expression of muscle specific genes in cultured rat cardiomyocytes. J Mol Cell Cardiol 26:789–795

    Article  PubMed  CAS  Google Scholar 

  15. Ikezu T, Okamoto T, Giambarella U, Yokota T, Nishimoto I (1995) In vivo coupling of insulin-like growth factor II/mannose 6-phosphate receptor to heteromeric G proteins. Distinct roles of cytoplasmic domains and signal sequestration by the receptor. J Biol Chem 270:29224–29228

    Article  PubMed  CAS  Google Scholar 

  16. Molkentin JD, Lu JR, Antos CL, Markham B, Richardson J, Robbins J, Grant SR, Olson EN (1998) A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell 93:215–228

    Article  PubMed  CAS  Google Scholar 

  17. Wang HG, Pathan N, Ethell IM et al. (1999) Ca-induced apoptosis through calcineurin dephosphorylation of Bad. Science 284:339–343

    PubMed  Google Scholar 

  18. Diep QN, El Mabrouk M, Yue P, Schiffrin EL (2002) Effect of AT(1) receptor blockade on cardiac apoptosis in angiotensin II-induced hypertension. Am J Physiol Heart Circ Physiol 282:H1635–H1641

    PubMed  CAS  Google Scholar 

  19. Gonzalez A, Lopez B, Ravassa S, et al (2002) Stimulation of cardiac apoptosis in essential hypertension: Potential role of angiotensin II. Hypertension 39:75–80

    Article  PubMed  CAS  Google Scholar 

  20. Zarrilli R, Colantuoni V, Bruni CB (1992) Regulation of insulin-like-growth-factor-II gene expression in rat liver cells. (erratum in 15;210:1079) . Eur J Biochem 209:445–452

    Article  PubMed  CAS  Google Scholar 

  21. Vogt AM, Htun P, Kluge A, Zimmermann R, Schaper W (1997) Insulin-like growth factor-II delays myocardial infarction in experimental coronary artery occlusion. Cardiovasc Res 33:469–477

    Article  PubMed  CAS  Google Scholar 

  22. Sun FL, Dean WL, Kelsey G, Allen ND, Reik W (1997) Transactivation of IGF2 in a mouse model of Beckwith-Wiedemann syndrome. Nature 389:809–815

    Article  PubMed  CAS  Google Scholar 

  23. Nishimoto I, Murayama Y, Katada T, Ui M, Ogata E (1989) Possible direct linkage of insulin-like growth factor-II receptor with guanine nucleotide-binding proteins. J Biol Chem 264:14029–14038

    PubMed  CAS  Google Scholar 

  24. Adams JW, Pagel AL, Means CK, Oksenberg D, Armstrong RC, Brown JH (2000) Cardiomyocyte apoptosis induced by Galphaq signaling is mediated by permeability transition pore formation and activation of the mitochondrial death pathway. Circ Res 87:1180–1187

    PubMed  CAS  Google Scholar 

  25. Huang CY, Hao LY, Buetow DE (2002) Insulin-like growth factor-induced hypertrophy of cultured adult rat cardiomyocytes is L-type calcium-channel-dependent. Mol Cell Biochem 231:51–59

    Article  PubMed  CAS  Google Scholar 

  26. Huang CY, Hao LY, Buetow DE (2002) Insulin-like growth factor-II induces hypertrophy of adult cardiomyocytes via two alternative pathways. Cell Biol Int 26:737–739

    Article  PubMed  CAS  Google Scholar 

  27. Yamamura T, Otani H, Nakao Y, Hattori R, Osako M, Imamura H (2001) IGF-I differentially regulates Bcl-xL and Bax and confers myocardial protection in the rat heart. Am J Physiol Heart Circ Physiol 280:H1191–H1200

    PubMed  CAS  Google Scholar 

  28. Hammerman MR (1987) Insulin-like growth factors and aging. Endocrinol Metab Clin North Am 16:995–1011

    PubMed  CAS  Google Scholar 

  29. Candido R, Srivastava P, Cooper ME, Burrell LM (2003) Diabetes mellitus: A cardiovascular disease. Curr Opin Investig Drugs 4:1088–1094

    PubMed  Google Scholar 

  30. Fiordaliso F, Li B, Latini R, et al (2000) Myocyte death in streptozotocin-induced diabetes in rats in angiotensin II- dependent. Lab Invest 80:513–527

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Chih-Yang Huang.

Additional information

The last two authors contributed equally.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kuo, WW., Liu, CJ., Chen, LM. et al. Cardiomyoblast apoptosis induced by insulin-like growth factor (IGF)-I resistance is IGF-II dependent and synergistically enhanced by angiotensin II. Apoptosis 11, 1075–1089 (2006). https://doi.org/10.1007/s10495-006-7028-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10495-006-7028-4

Keywords

Navigation